Literature DB >> 20675374

Erythrocyte tropomodulin isoforms with and without the N-terminal actin-binding domain.

Weijuan Yao1, Lanping Amy Sung.   

Abstract

Erythrocyte tropomodulin (E-Tmod or Tmod1) of 41 kDa is a tropomyosin (TM)-binding protein that caps the slow-growing end of the actin filaments. Its N-terminal half is flexible, whereas the C-terminal half has a single domain structure. E-Tmod/TM5 complex may function as a "molecular ruler" generating actin protofilaments of ∼37 nm. Here we report the discovery of a short isoform of 29 kDa that lacks the N-terminal actin-binding domain (N-ABD) but retains the C-terminal actin-binding domain (C-ABD). E-Tmod29 can be generated by alternative splicing from an upstream promoter or by multiple transcriptional start sites from a downstream promoter. Promoter switching leads to a surge of E-Tmod41 in reticulocytes, which degrades quickly in the cytosol. We expressed recombinant isoforms in Escherichia coli and tested their binding toward TM5, G-actin, and F-actin. Solid-phase binding assays show that, without the N-terminal 102 residues, E-Tmod29 binds to TM5 or G-actin more strongly than E-Tmod41 does, but barely binds to F-actin after TM5 binding. Differential bindings explain the distinct localizations of E-Tmod29 in the cytosol and E-Tmod41 on the membrane. Sequential bindings and immunofluorescent staining further suggest that 1) TM5 binding to E-Tmod41 may open up the flexible N-terminal half, exposing N-ABD and unblocking C-ABD; 2) N-ABD binds to F-actin and C-ABD binds to G-actin; and 3) F-actin binding to N-ABD may prevent G-actin from binding to C-ABD. E-Tmod29 may thus modulate the availability of TM5 and G-actin for E-Tmod41 to construct the protofilament-based membrane skeletal network for circulating erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675374      PMCID: PMC2951215          DOI: 10.1074/jbc.M110.130278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.

Authors:  Guang Yang; Shu-Ching Huang; Jane Y Wu; Edward J Benz
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

2.  Ubiquitin is conjugated to the cytoskeletal protein alpha-spectrin in mature erythrocytes.

Authors:  D Corsi; L Galluzzi; R Crinelli; M Magnani
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

3.  Structure and organization of the human ankyrin-1 gene. Basis for complexity of pre-mRNA processing.

Authors:  P G Gallagher; W T Tse; A L Scarpa; S E Lux; B G Forget
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

Review 4.  Evolution of spectrin function in cytoskeletal and membrane networks.

Authors:  Anthony J Baines
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

5.  Cloning of tropomodulin cDNA and localization of gene transcripts during mouse embryogenesis.

Authors:  M Ito; B Swanson; M A Sussman; L Kedes; G Lyons
Journal:  Dev Biol       Date:  1995-01       Impact factor: 3.582

6.  Enucleation of cultured mouse fetal erythroblasts requires Rac GTPases and mDia2.

Authors:  Peng Ji; Senthil Raja Jayapal; Harvey F Lodish
Journal:  Nat Cell Biol       Date:  2008-02-10       Impact factor: 28.824

7.  Identification and characterization of tropomodulin and tropomyosin in the adult rat lens.

Authors:  M K Woo; V M Fowler
Journal:  J Cell Sci       Date:  1994-05       Impact factor: 5.285

8.  Immunolocalization of tropomodulin, tropomyosin and actin in spread human erythrocyte skeletons.

Authors:  J A Ursitti; V M Fowler
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

9.  Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening.

Authors:  D E Discher; R Winardi; P O Schischmanoff; M Parra; J G Conboy; N Mohandas
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

10.  Aberrant myofibril assembly in tropomodulin1 null mice leads to aborted heart development and embryonic lethality.

Authors:  Kimberly L Fritz-Six; Patrick R Cox; Robert S Fischer; Bisong Xu; Carol C Gregorio; Huda Y Zoghbi; Velia M Fowler
Journal:  J Cell Biol       Date:  2003-12-01       Impact factor: 10.539

View more
  6 in total

Review 1.  Tropomodulins: pointed-end capping proteins that regulate actin filament architecture in diverse cell types.

Authors:  Sawako Yamashiro; David S Gokhin; Sumiko Kimura; Roberta B Nowak; Velia M Fowler
Journal:  Cytoskeleton (Hoboken)       Date:  2012-05-04

2.  Mechanism of actin filament pointed-end capping by tropomodulin.

Authors:  Jampani Nageswara Rao; Yadaiah Madasu; Roberto Dominguez
Journal:  Science       Date:  2014-07-25       Impact factor: 47.728

Review 3.  Tropomodulins and tropomyosins: working as a team.

Authors:  Mert Colpan; Natalia A Moroz; Alla S Kostyukova
Journal:  J Muscle Res Cell Motil       Date:  2013-07-05       Impact factor: 2.698

4.  Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.

Authors:  Guan Wang; Jérôme Durussel; Jonathan Shurlock; Martin Mooses; Noriyuki Fuku; Georgie Bruinvels; Charles Pedlar; Richard Burden; Andrew Murray; Brendan Yee; Anne Keenan; John D McClure; Pierre-Edouard Sottas; Yannis P Pitsiladis
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

5.  Tropomodulin1 Expression Increases Upon Maturation in Dendritic Cells and Promotes Their Maturation and Immune Functions.

Authors:  Xianmei Liu; Xue Xia; Xifu Wang; Jing Zhou; Lanping Amy Sung; Jinhua Long; Xueyu Geng; Zhu Zeng; Weijuan Yao
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

6.  Fluid Shear Stress Upregulates E-Tmod41 via miR-23b-3p and Contributes to F-Actin Cytoskeleton Remodeling during Erythropoiesis.

Authors:  Weiyun Mu; Xifu Wang; Xiaolan Zhang; Sida Zhu; Dagong Sun; Weibo Ka; Lanping Amy Sung; Weijuan Yao
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.